Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report
- PMID: 35334516
- PMCID: PMC8949814
- DOI: 10.3390/medicina58030339
Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report
Abstract
Persistent infection with human papillomavirus (HPV) causes almost all cervical precancerous lesions and cancers. Bivalent, quadrivalent, and nonavalent HPV vaccines effectively prevent high-grade cervical intraepithelial neoplasia (CIN3). The effectiveness of HPV vaccination against CIN3 is 97-100% in HPV-naïve populations and 44-61% in the overall population. Although HPV vaccination has substantially reduced the incidence of cervical cancers, several cases of precancerous cervical lesions in HPV-vaccinated patients have been reported. We report the clinical case of a 19-year-old woman whose first Pap smear was diagnosed as a high-grade squamous intraepithelial lesion (HSIL) after quadrivalent HPV vaccination. Colposcopy and cervical biopsy were performed, revealing HSIL/CIN3. Our multidisciplinary team decided to take a conservative approach with follow-up visits with cervical biopsies of this young patient. After six months, spontaneous regression of high-grade cervical dysplasia was observed. Although HPV immunization has shown to be extremely effective in preventing a high proportion of cervical precancerous lesions and cervical cancers, HPV vaccines do not protect against all oncogenic high-risk HPV genotypes. Consequently, healthcare providers must encourage HPV-vaccinated women to still regularly attend national cervical screening programs.
Keywords: Papanicolaou test; cervical intraepithelial neoplasia; papillomavirus vaccines.
Conflict of interest statement
The authors declare no conflict of interests.
Figures


Similar articles
-
Cervical Intraepithelial Neoplasia 3 (Cervical Intraepithelial Neoplasia 3/High-Grade Squamous Intraepithelial Lesion) in Human Papillomavirus-Vaccinated Women-Results From a Tertiary Referral Center.J Low Genit Tract Dis. 2022 Apr 1;26(2):122-126. doi: 10.1097/LGT.0000000000000653. J Low Genit Tract Dis. 2022. PMID: 35019900
-
Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.Virol J. 2017 Nov 6;14(1):214. doi: 10.1186/s12985-017-0879-1. Virol J. 2017. PMID: 29110680 Free PMC article.
-
Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.BMJ Open. 2017 Aug 18;7(8):e015867. doi: 10.1136/bmjopen-2017-015867. BMJ Open. 2017. PMID: 28821519 Free PMC article. Clinical Trial.
-
Aptima HPV messenger RNA testing and histopathologic follow-up in women with HSIL cytology: A study emphasizing additional review of HPV-negative cases.Cancer Cytopathol. 2021 Aug;129(8):622-631. doi: 10.1002/cncy.22421. Epub 2021 Mar 25. Cancer Cytopathol. 2021. PMID: 33764649 Review.
-
Assessing the risk of cervical neoplasia in the post-HPV vaccination era.Int J Cancer. 2023 Mar 15;152(6):1060-1068. doi: 10.1002/ijc.34286. Epub 2022 Oct 10. Int J Cancer. 2023. PMID: 36093582 Free PMC article. Review.
Cited by
-
E6/E7 mRNA Expression of the Most Prevalent High-Risk HPV Genotypes in Cervical Samples from Serbian Women.Diagnostics (Basel). 2023 Feb 28;13(5):917. doi: 10.3390/diagnostics13050917. Diagnostics (Basel). 2023. PMID: 36900061 Free PMC article.
-
The Impact of SARS-CoV-2 Pandemic on Patients Undergoing Radiation Therapy for Advanced Cervical Cancer at a Romanian Academic Center: A Four-Year Retrospective Analysis.Diagnostics (Basel). 2022 Jun 17;12(6):1488. doi: 10.3390/diagnostics12061488. Diagnostics (Basel). 2022. PMID: 35741299 Free PMC article.
References
-
- Joura E.A., Ault K.A., Bosch F.X., Brown D., Cuzick J., Ferris D., Garland S.M., Giuliano A.R., Hernandez-Avila M., Huh W., et al. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. Cancer Epidemiol. Biomark. Prev. 2014;23:1997–2008. doi: 10.1158/1055-9965.EPI-14-0410. - DOI - PubMed